Metabolic Syndrome Tracks With Worse Oral Health Before Adjustment in Fasa Cohort

A large Iranian cohort study has drawn a clear line between metabolic syndrome and poorer oral-dental health, but only at the level of crude association. In the Fasa Adult Cohort Study, participants with metabolic syndrome showed statistically significant differences across every component of the Decayed, Missing, and Filled Teeth index, yet those relationships did not hold once demographic and lifestyle factors entered the model.

The finding is clinically familiar in a different way: oral disease and cardiometabolic risk often travel together through shared exposures, not necessarily through a direct one-way cause. Poor diet quality, smoking, lower socioeconomic access to dental care, reduced self-care, chronic inflammation, and long-standing systemic disease can all leave a signature in both the mouth and the metabolic profile.

A 10,092-Person Cohort and a High Burden of Metabolic Risk

The analysis used baseline data from 10,092 participants in the Fasa Adult Cohort, a population sample large enough to capture a substantial burden of cardiometabolic disease. Metabolic syndrome prevalence reached 24.6% in this group. Individual components were also common: hypertension was present in 20.1%, diabetes mellitus in 12.3%, hypertriglyceridemia in 28.2%, reduced high-density lipoprotein cholesterol in 26.8%, and elevated waist circumference in 3.2%.

Those numbers matter because oral findings were not measured in a vacuum. The DMFT index, long used to quantify cumulative tooth damage, reflects the slow accumulation of decay, extraction, and restorative treatment over years. In a cohort shaped by middle-age and later-life health patterns, DMFT does not merely describe teeth; it often mirrors broader access to prevention, chronic disease management, and health behavior.

Oral health status in this study showed substantial tooth burden. Mean values were 17.33 ± 10.05 for sound teeth, 9.20 ± 7.22 for decayed teeth, 14.67 ± 10.05 for missing teeth, and 0.63 ± 1.64 for filled teeth. Those figures point to a population in which missing teeth were common and restorative treatment remained relatively limited.

Every DMFT Component Moved in the Same Direction on Univariate Testing

Bivariate testing linked metabolic syndrome status with all DMFT components. Sound teeth differed by metabolic syndrome status (_P_ = 0.038), decayed teeth by _P_ = 0.001, missing teeth by _P_ = 0.045, and filled teeth by _P_ = 0.001.

The pattern is biologically plausible. Insulin resistance, dyslipidemia, and central adiposity may contribute to a pro-inflammatory state that can aggravate periodontal disease and impair tissue repair. In parallel, the same behavioral and social pressures that increase metabolic risk can limit tooth brushing frequency, dental attendance, and timely restorative care. When those forces accumulate over years, decay and tooth loss begin to cluster with the same reliability seen in other chronic disease pairings.

One sentence captures the key tension in the dataset: the crude association was real, but it was not independent.

After multivariable binary logistic regression adjusted for demographic and lifestyle covariates, none of the dental indicators remained independently associated with metabolic syndrome status, with all _P_ values exceeding 0.05. The regression result changes the interpretation in an important way. Oral-dental measures may mark a person’s overall health burden, but in this cohort they did not function as standalone predictors of metabolic syndrome once confounding was addressed.

This is the point where epidemiology becomes more clinically useful than intuition. A mouth with multiple decayed or missing teeth may still identify a patient at elevated health risk, but not because dental pathology alone is driving metabolic syndrome. More likely, the dental findings sit inside a broader framework of age, behavior, access to care, and chronic disease history that also shapes metabolic status.

For clinicians, that distinction affects how screening should be approached. A damaged dentition should prompt attention to diet, obesity, blood pressure, glycemic status, and lipid profile, but it does not justify treating oral indicators as independent metabolic screening markers on their own.

What the Data Support at the Bedside

The study supports a practical, integrated view of prevention. Dental clinics and primary care settings see overlapping populations, and each setting may encounter early signs of the other’s burden. A patient with extensive tooth loss or untreated decay may also carry undiagnosed hypertension, dysglycemia, or central obesity. Likewise, a patient already known to have metabolic syndrome may need oral health assessment because chronic disease management often leaves dental care unaddressed.

The cross-sectional design limits causal interpretation. Baseline data can show co-occurrence and adjusted association, but cannot establish whether metabolic syndrome worsens oral health, whether oral disease intensifies metabolic risk, or whether both arise from the same underlying social and behavioral exposures. The absence of an independent association after adjustment also suggests that any future work will need richer detail on diet, smoking, oral hygiene practices, income, education, and health-care utilization.

Still, the cohort is large enough to carry weight. A 10,092-participant sample with a 24.6% metabolic syndrome prevalence provides a broad view of real-world risk, not a narrow clinic-based snapshot. The result should discourage simplistic claims that DMFT scores can stand in for metabolic screening, while preserving the more modest and defensible conclusion that poor oral health and metabolic risk often coexist in the same patients.

The practical message is straightforward: oral findings can flag vulnerability, but they do not replace metabolic assessment. In this cohort, the overlap was visible until confounding was removed, and that is where the signal stopped.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by Nature Medical Research.